Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosis

Kappos L., Gold R., Miller D., MacManus D. G., Havrdova E., Limmroth V., ...More

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 68
  • City: Massachusetts
  • Country: United States Of America
  • Istanbul University Affiliated: No